Deciphering the molecular and clinical characteristics of TREM2, HCST, and TYROBP in cancer immunity: A comprehensive pan-cancer study

Deciphering the molecular and clinical characteristics of TREM2, HCST, and TYROBP in cancer immunity: A comprehensive pan-cancer study

Background: Hematopoietic cell signal transducer (HCST) and tyrosine kinase-binding protein (TYROBP) are triggering receptors expressed on myeloid cells 2 (TREM2), which are pivotal in the immune response to disease. Despite growing evidence underscoring the significance of TREM2, HCST, and TYROBP i...

Full description

Bibliographic Details
Main Authors: Piao Zheng, Yejun Tan, Qing Liu, Changwu Wu, Jing Kang, Shuzhi Liang, Lemei Zhu, Kuipo Yan, Lingfeng Zeng, Bolin Chen
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Heliyon
Subjects:
Triggering receptor expressed on myeloid cells 2 (TREM2)
Hematopoietic cell signal transducer (HCST)
TYRO protein tyrosine kinase-binding protein (TYROBP)
Pan-cancer
Tumor immunity
Online Access:http://www.sciencedirect.com/science/article/pii/S240584402403024X

Internet

http://www.sciencedirect.com/science/article/pii/S240584402403024X

Similar Items